Ernexa Therapeutics Inc. (ERNA) Short term Debt (2013 - 2026)
Ernexa Therapeutics' (ERNA) quarterly Short term Debt came in at $41000.0 in Q1 2026, little changed on a QoQ basis from $41000.0 in Q4 2025.
Ernexa Therapeutics Inc. (ERNA) Short term Debt (2013 - 2026) Analysis & Trends
Ernexa Therapeutics (ERNA) has 13 years of Short term Debt data on file, last reported at $41000.0 in Q1 2026.
- Quarterly Short term Debt changed N/A year-over-year to $41000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $41000.0 (changed N/A YoY) and the FY2025 annual result came in at $41000.0, changed N/A from the prior year.
- Short term Debt held at $41000.0 in Q1 2026, from $41000.0 in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $1.8 million in Q4 2022 to a low of $41000.0 in Q2 2025.
- A 4-year average of $610666.7 and a median of $41000.0 in 2025 frame the typical range for Short term Debt.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41,000.00 |
| Dec 31, 2025 | 41,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Jun 30, 2025 | 41,000.00 |
| Mar 31, 2023 | 1.75 Mn |
| Dec 31, 2022 | 1.75 Mn |
| Sep 30, 2021 | 410,000.00 |
| Jun 30, 2021 | 410,000.00 |
| Mar 31, 2021 | 410,000.00 |
| Dec 31, 2020 | 410,000.00 |
| Sep 30, 2020 | 1.72 Mn |
| Mar 31, 2020 | 1.99 Mn |
| Dec 31, 2019 | 2.74 Mn |
| Sep 30, 2019 | 1.00 Mn |
| Jun 30, 2019 | 1.08 Mn |
| Mar 31, 2019 | 1.00 Mn |
| Dec 31, 2018 | 410,000.00 |
| Jun 30, 2018 | 2.21 Mn |
| Mar 31, 2018 | 1.94 Mn |
| Dec 31, 2017 | 5.06 Mn |